Bone Biologics Corporation (BBLGW) Capital expenditures
Bone Biologics Corporation (BBLGW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$504FY2016
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | $504 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More BBLGW financial trends
BBLGW RevenueBBLGW Net incomeBBLGW Net marginBBLGW Gross profitBBLGW Gross marginBBLGW Operating incomeBBLGW Operating marginBBLGW Operating cash flowBBLGW Free cash flowBBLGW Return on equityBBLGW Stock buybacksBBLGW Dividends paidBBLGW Total assetsBBLGW Total liabilitiesBBLGW Shareholders’ equityBBLGW overview →